GC2402 Study Site 106 — Sherman, Texas

GC2402 Study Site 106 is a clinical research site located in Sherman, Texas, United States 75092.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

GC2402 Study Site 106 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy).

Sponsors: Grifols Therapeutics LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Sherman

Browse all research sites in Texas · View every site in Sherman

• Texas Cancer Center-Sherman
• Sherman Clinical Research
• Research Site
• Texas Institute for Neurological Disorders
• Texas Oncology-Sherman
• Texas Oncology, PA at Texas Cancer Center - Sherman
• Novartis Investigative Site
• GSK Investigational Site
• Texas Institute for Neurological Disorders - Sherman
• Revival Research Institute, LLC
• Clinical Trial Site
• Medrasa Clinical Research

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GC2402 Study Site 106?

GC2402 Study Site 106 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GC2402 Study Site 106 conducted?

GC2402 Study Site 106 has 1 clinical trials on record, with 1 currently active. Their work covers CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy).

Is GC2402 Study Site 106 accredited by Crixeo Clinical Trials?

GC2402 Study Site 106 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GC2402 Study Site 106?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.